795 related articles for article (PubMed ID: 32078591)
21. Influenza vaccine effectiveness against medically attended influenza illness in Beijing, China, 2014/15 season.
Ma C; Pan Y; Zhang L; Zhang Y; Wu S; Sun Y; Duan W; Zhang M; Wang Q; Yang P
Hum Vaccin Immunother; 2017 Oct; 13(10):2379-2384. PubMed ID: 28846480
[TBL] [Abstract][Full Text] [Related]
22. Influenza Activity - United States, 2015-16 Season and Composition of the 2016-17 Influenza Vaccine.
Davlin SL; Blanton L; Kniss K; Mustaquim D; Smith S; Kramer N; Cohen J; Cummings CN; Garg S; Flannery B; Fry AM; Grohskopf LA; Bresee J; Wallis T; Sessions W; Garten R; Xu X; Elal AI; Gubareva L; Barnes J; Wentworth DE; Burns E; Katz J; Jernigan D; Brammer L
MMWR Morb Mortal Wkly Rep; 2016 Jun; 65(22):567-75. PubMed ID: 27281364
[TBL] [Abstract][Full Text] [Related]
23. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.
Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y
J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728
[TBL] [Abstract][Full Text] [Related]
24. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
[TBL] [Abstract][Full Text] [Related]
25. Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020.
Skowronski DM; Zou M; Sabaiduc S; Murti M; Olsha R; Dickinson JA; Gubbay JB; Croxen MA; Charest H; Jassem A; Krajden M; Bastien N; Li Y; De Serres G
Euro Surveill; 2020 Feb; 25(7):. PubMed ID: 32098644
[TBL] [Abstract][Full Text] [Related]
26. Early estimates of seasonal influenza vaccine effectiveness--United States, January 2013.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2013 Jan; 62(2):32-5. PubMed ID: 23325354
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16.
Yaron-Yakoby H; Sefty H; Pando R; Dichtiar R; Katz MA; Stein Y; Mandelboim M; Mendelson E; Shohat T; Glatman-Freedman A;
Euro Surveill; 2018 Feb; 23(7):. PubMed ID: 29471622
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
[TBL] [Abstract][Full Text] [Related]
29. Prevention and Control of Seasonal Influenza with Vaccines.
Grohskopf LA; Sokolow LZ; Broder KR; Olsen SJ; Karron RA; Jernigan DB; Bresee JS
MMWR Recomm Rep; 2016 Aug; 65(5):1-54. PubMed ID: 27560619
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.
Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Johnston J; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Byford R; Gallagher N; Sinnathamby M; Yonova I; Pathirannehelage S; Donati M; Moore C; de Lusignan S; McMenamin J; Zambon M
Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684603
[TBL] [Abstract][Full Text] [Related]
31. Update: influenza activity - United States, 2011-12 season and composition of the 2012-13 influenza vaccine.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jun; 61(22):414-20. PubMed ID: 22672977
[TBL] [Abstract][Full Text] [Related]
32. 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.
Kissling E; Valenciano M; Pozo F; Vilcu AM; Reuss A; Rizzo C; Larrauri A; Horváth JK; Brytting M; Domegan L; Korczyńska M; Meijer A; Machado A; Ivanciuc A; Višekruna Vučina V; van der Werf S; Schweiger B; Bella A; Gherasim A; Ferenczi A; Zakikhany K; O Donnell J; Paradowska-Stankiewicz I; Dijkstra F; Guiomar R; Lazar M; Kurečić Filipović S; Johansen K; Moren A;
Influenza Other Respir Viruses; 2018 Jul; 12(4):423-437. PubMed ID: 29125681
[TBL] [Abstract][Full Text] [Related]
33. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
Mouratidou E; Lambrou A; Andreopoulou A; Gioula G; Exindari M; Kossyvakis A; Pogka V; Mentis A; Georgakopoulou T; Lytras T
Vaccine; 2020 Mar; 38(12):2715-2724. PubMed ID: 32033848
[TBL] [Abstract][Full Text] [Related]
34. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
[TBL] [Abstract][Full Text] [Related]
35. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
[TBL] [Abstract][Full Text] [Related]
36. Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019.
Kissling E; Rose A; Emborg HD; Gherasim A; Pebody R; Pozo F; Trebbien R; Mazagatos C; Whitaker H; Valenciano M;
Euro Surveill; 2019 Feb; 24(8):. PubMed ID: 30808440
[TBL] [Abstract][Full Text] [Related]
37. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.
Castilla J; Martinez-Baz I; Martinez-Artola V; Fernandez-Alonso M; Reina G; Guevara M; Garcia Cenoz M; Elia F; Alvarez N; Barricarte A; Ezpeleta C
Euro Surveill; 2013 Feb; 18(7):2. PubMed ID: 23449182
[TBL] [Abstract][Full Text] [Related]
38. Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013.
El Omeiri N; Azziz-Baumgartner E; Thompson MG; ; Clará W; Cerpa M; Palekar R; Mirza S; Ropero-Álvarez AM
Vaccine; 2018 Jun; 36(24):3555-3566. PubMed ID: 28648543
[TBL] [Abstract][Full Text] [Related]
39. Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.
Russell K; Chung JR; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Flannery B
Vaccine; 2018 Feb; 36(10):1272-1278. PubMed ID: 29402578
[TBL] [Abstract][Full Text] [Related]
40. Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016.
Chambers C; Skowronski DM; Sabaiduc S; Winter AL; Dickinson JA; De Serres G; Gubbay JB; Drews SJ; Martineau C; Eshaghi A; Krajden M; Bastien N; Li Y
Euro Surveill; 2016; 21(11):30168. PubMed ID: 27020673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
